Wyeth Wins Philly Fen-Phen Case

Law360, New York (October 10, 2008, 12:00 AM EDT) -- A Philadelphia jury has ruled in favor of Wyeth Pharmaceuticals Inc. in a wrongful death suit over the diet drug Pondimin, which spurred thousands of lawsuits after Wyeth yanked it off the shelves amid claims that it causes heart disease.

After a trial before Judge Gary S. Glazer in the Philadelphia Court of Common Pleas, a jury unanimously ruled in Wyeth's favor, the company said on Friday.

The case alleges that Pondimin, part of the anti-obesity drug treatment fen-phen, caused the primary pulmonary hypertension that eventually...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.